United States · FDA National Drug Code directory

Famotidine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55111-396_e818465f-a1ca-0e6a-f18c-cf2cb2a2cc82
Product NDC
55111-396
Form
TABLET
Composition / generic term
Famotidine
Labeler
Dr.Reddys Laboratories Limited
Marketing category
ANDA
Marketing start / end (source format)
20060930
Source listing expiry
20261231

Source-listed ingredients

  • FAMOTIDINE — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (55111-396-01) / 100 TABLET in 1 BOTTLE · 55111-396-01
  • 1 BLISTER PACK in 1 CARTON (55111-396-08) / 8 TABLET in 1 BLISTER PACK · 55111-396-08
  • 1 BOTTLE in 1 CARTON (55111-396-13) / 130 TABLET in 1 BOTTLE · 55111-396-13
  • 5 BLISTER PACK in 1 CARTON (55111-396-16) / 5 TABLET in 1 BLISTER PACK · 55111-396-16
  • 1 BOTTLE in 1 CARTON (55111-396-32) / 170 TABLET in 1 BOTTLE · 55111-396-32
  • 1 BOTTLE in 1 CARTON (55111-396-35) / 25 TABLET in 1 BOTTLE · 55111-396-35
  • 2 BOTTLE in 1 CARTON (55111-396-44) / 100 TABLET in 1 BOTTLE · 55111-396-44
  • 1 BOTTLE in 1 CARTON (55111-396-50) / 50 TABLET in 1 BOTTLE · 55111-396-50
  • 1 BOTTLE in 1 CARTON (55111-396-65) / 65 TABLET in 1 BOTTLE · 55111-396-65
  • 1 BOTTLE in 1 CARTON (55111-396-90) / 90 TABLET in 1 BOTTLE · 55111-396-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →